Clofedanol: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
<div style="float: right;"> | <div style="float: right;"> | ||
[[File: | [[File:Chlophedianol.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]</div> | ||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
'''Clofedanol''' ([[International Nonproprietary Name|INN]]) or '''chlophedianol''' ([[British Approved Name|BAN]]) is a centrally acting [[cough medicine|cough suppressant]] used in the treatment of dry cough. Clofedanol has [[local anesthetic]] and [[antihistamine]] properties, and may have [[anticholinergic]] effects at high doses.<ref>{{cite web | url = http://www.biam2.org/www/Sub4074.html | title = Clofedanol | accessdate = 2007-04-15 | date = 1998-07-24 | publisher = BIAM|language=fr}}</ref> It is marketed in [[Canada]] under the trade name '''Ulone''', but is not available currently in the [[United States]]. In August 2009, Centrix Pharmaceutical announced the launch of a cough syrup containing a mixture of clophedianol and pseudoephedrine, marketed under the brand name ''Clofera''. It has a release to market date in the beginning of the fourth quarter 2009.<ref>{{cite web | url = http://www.cenrx.com/news.php | title = Centrix Pharmaceutical Announces Clofera(TM), a Unique Antitussive and Nasal Decongestant for the Temporary Relief of Cough and Nasal Congestion | accessdate = 2009-09-27 | publisher = Cenrx.com}}</ref> Chlophedianol was approved for OTC status in 1987 by the FDA OTC monograph process<ref>{{cite web | url = http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Over-the-CounterOTCDrugs/StatusofOTCRulemakings/ucm114742.pdf | title = Department of Health and Human Services. Food and Drug Administration. 21 CFR Parts 310, 341, and 369. Docket No. 76N-052T. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the0counter human use; final monograph for OTC antitussive drug products. Federal Register 1987;52(155):30042-57 | date = 1987-08-12 | publisher = FDA.gov}}</ref> and its safety and efficacy data are limited. | '''Clofedanol''' ([[International Nonproprietary Name|INN]]) or '''chlophedianol''' ([[British Approved Name|BAN]]) is a centrally acting [[cough medicine|cough suppressant]] used in the treatment of dry cough. Clofedanol has [[local anesthetic]] and [[antihistamine]] properties, and may have [[anticholinergic]] effects at high doses.<ref>{{cite web | url = http://www.biam2.org/www/Sub4074.html | title = Clofedanol | accessdate = 2007-04-15 | date = 1998-07-24 | publisher = BIAM|language=fr}}</ref> It is marketed in [[Canada]] under the trade name '''Ulone''', but is not available currently in the [[United States]]. In August 2009, Centrix Pharmaceutical announced the launch of a cough syrup containing a mixture of clophedianol and pseudoephedrine, marketed under the brand name ''Clofera''. It has a release to market date in the beginning of the fourth quarter 2009.<ref>{{cite web | url = http://www.cenrx.com/news.php | title = Centrix Pharmaceutical Announces Clofera(TM), a Unique Antitussive and Nasal Decongestant for the Temporary Relief of Cough and Nasal Congestion | accessdate = 2009-09-27 | publisher = Cenrx.com}}</ref> Chlophedianol was approved for OTC status in 1987 by the FDA OTC monograph process<ref>{{cite web | url = http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Over-the-CounterOTCDrugs/StatusofOTCRulemakings/ucm114742.pdf | title = Department of Health and Human Services. Food and Drug Administration. 21 CFR Parts 310, 341, and 369. Docket No. 76N-052T. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the0counter human use; final monograph for OTC antitussive drug products. Federal Register 1987;52(155):30042-57 | date = 1987-08-12 | publisher = FDA.gov}}</ref> and its safety and efficacy data are limited. | ||
==Synthesis== | ==Synthesis== | ||
[[File:Clofedanol1.png|thumb|center|500px|Clofedanol synthesis: R. Lorenz and H. Henecka, {{US Patent|3,031,377}} (1962).]] | [[File:Clofedanol1.png|thumb|center|500px|Clofedanol synthesis: R. Lorenz and H. Henecka, {{US Patent|3,031,377}} (1962).]] | ||
== References == | == References == | ||
Latest revision as of 19:02, 7 April 2015
|
WikiDoc Resources for Clofedanol |
|
Articles |
|---|
|
Most recent articles on Clofedanol |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Clofedanol at Clinical Trials.gov Clinical Trials on Clofedanol at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Clofedanol
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Clofedanol Discussion groups on Clofedanol Patient Handouts on Clofedanol Directions to Hospitals Treating Clofedanol Risk calculators and risk factors for Clofedanol
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Clofedanol |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Clofedanol (INN) or chlophedianol (BAN) is a centrally acting cough suppressant used in the treatment of dry cough. Clofedanol has local anesthetic and antihistamine properties, and may have anticholinergic effects at high doses.[1] It is marketed in Canada under the trade name Ulone, but is not available currently in the United States. In August 2009, Centrix Pharmaceutical announced the launch of a cough syrup containing a mixture of clophedianol and pseudoephedrine, marketed under the brand name Clofera. It has a release to market date in the beginning of the fourth quarter 2009.[2] Chlophedianol was approved for OTC status in 1987 by the FDA OTC monograph process[3] and its safety and efficacy data are limited.
Synthesis
References
- ↑ "Clofedanol" (in français). BIAM. 1998-07-24. Retrieved 2007-04-15.
- ↑ "Centrix Pharmaceutical Announces Clofera(TM), a Unique Antitussive and Nasal Decongestant for the Temporary Relief of Cough and Nasal Congestion". Cenrx.com. Retrieved 2009-09-27.
- ↑ "Department of Health and Human Services. Food and Drug Administration. 21 CFR Parts 310, 341, and 369. Docket No. 76N-052T. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the0counter human use; final monograph for OTC antitussive drug products. Federal Register 1987;52(155):30042-57" (PDF). FDA.gov. 1987-08-12.